- Home
- BHAT vs VRAX Comparison
BHAT vs VRAX Comparison
Compare BHAT & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- VRAX
- Stock Information
- Founded
- BHAT 2010
- VRAX 2013
- Country
- BHAT China
- VRAX United Kingdom
- Employees
- BHAT N/A
- VRAX N/A
- Industry
- BHAT Recreational Games/Products/Toys
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BHAT Consumer Discretionary
- VRAX Health Care
- Exchange
- BHAT Nasdaq
- VRAX Nasdaq
- Market Cap
- BHAT 59.1M
- VRAX 2.8M
- IPO Year
- BHAT 2019
- VRAX 2022
- Fundamental
- Price
- BHAT $1.41
- VRAX $0.51
- Analyst Decision
- BHAT
- VRAX Strong Buy
- Analyst Count
- BHAT 0
- VRAX 1
- Target Price
- BHAT N/A
- VRAX $3.00
- AVG Volume (30 Days)
- BHAT 85.7K
- VRAX 274.0K
- Earning Date
- BHAT 12-22-2025
- VRAX 01-01-0001
- Dividend Yield
- BHAT N/A
- VRAX N/A
- EPS Growth
- BHAT N/A
- VRAX N/A
- EPS
- BHAT N/A
- VRAX N/A
- Revenue
- BHAT $18,724,190.00
- VRAX $6,331.00
- Revenue This Year
- BHAT N/A
- VRAX $217,274.83
- Revenue Next Year
- BHAT N/A
- VRAX N/A
- P/E Ratio
- BHAT N/A
- VRAX N/A
- Revenue Growth
- BHAT N/A
- VRAX N/A
- 52 Week Low
- BHAT $1.34
- VRAX $0.50
- 52 Week High
- BHAT $27.59
- VRAX $3.20
- Technical
- Relative Strength Index (RSI)
- BHAT 27.82
- VRAX 28.53
- Support Level
- BHAT $1.34
- VRAX $0.57
- Resistance Level
- BHAT $1.58
- VRAX $0.64
- Average True Range (ATR)
- BHAT 0.08
- VRAX 0.04
- MACD
- BHAT -0.02
- VRAX -0.01
- Stochastic Oscillator
- BHAT 18.42
- VRAX 4.52
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).